Liposomal Amphotericin B Associated With Severe Hyperphosphatemia

    loading  Checking for direct PDF access through Ovid


We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.

    loading  Loading Related Articles